Anti-IFI30 antibodies are used in the immunodetection of the protein IFI30 lysosomal thiol reductase. In humans, the canonical protein has a reported length of 250 amino acid residues and a mass of 28 kDa. Its subcellular localization is in the lysosomes and is secreted. It is notably widely expressed in many tissue types. A member of the GILT protein family, IFI30 is known to be involved with protein stabilization. Post-translational modifications have been described, including N-glycosylation and protein cleavage. Synonyms for this target antigen include IP-30, IP30, gamma-interferon-inducible lysosomal thiol reductase, gamma-interferon-inducible protein IP-30, and GILT. IFI30 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of IFI30 antibodies have been mentioned in research publications and have associated citations. ELISA, Western Blot, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are common applications for these antibodies.